Modifiers 25 and 59 are simultaneously the most useful and most scrutinized tools in a medical biller's toolkit. Used correctly, they unlock reimbursement for legitimate additional services that payers would otherwise bundle or deny. Used incorrectly — or used reflexively without meeting the specific criteria — they become the basis for False Claims Act liability.
The OIG's 2026 Work Plan specifically identifies modifier 25 and modifier 59 use as priority audit targets, continuing a multi-year pattern of heightened scrutiny. Practices that use these modifiers at high rates without airtight documentation will face post-payment audits.
Modifier 25 — The Significant, Separately Identifiable E/M
Modifier 25 is appended to an E/M service to indicate that it was significant and separately identifiable from another procedure performed on the same day. The classic scenario: a patient comes in for a scheduled injection, but during the visit the physician also evaluates a separate condition and that evaluation is billed as an E/M.
The critical requirement is that the E/M must be for a different condition, different problem, or different clinical question than the procedure performed. If the E/M is simply the pre-service evaluation for the procedure — checking that the patient is appropriate for the injection — it is not separately billable with modifier 25.
Documentation must clearly show that a significant, separately identifiable evaluation occurred. The note should have two distinct sections: one addressing the condition treated by the procedure, and another addressing the separately evaluated problem. The E/M should stand on its own — if you stripped out the procedure documentation, the E/M note should still justify the level billed.
The Most Common Modifier 25 Mistakes
Mistake one: using modifier 25 every time a procedure is performed, regardless of whether a separate E/M actually occurred. Some practices treat modifier 25 as a routine add-on to increase revenue. Auditors recognize this pattern immediately — when every procedure claim includes modifier 25 from the same provider, it's a red flag.
Mistake two: documenting the procedure pre-service evaluation as the E/M. If your note says "Patient presents for steroid injection. Reviewed indication, no contraindications noted. Injection performed" — that is not a separately identifiable E/M. That is pre-procedure documentation. You cannot bill an E/M with modifier 25 for that visit.
Mistake three: using modifier 25 for the E/M when both services address the same condition. Seeing a patient for a skin lesion, excising the lesion, and billing a 99213-25 alongside the excision code — if the E/M documentation only addresses the lesion that was excised, modifier 25 is not appropriate.
Modifier 59 vs. X Modifiers
Modifier 59 indicates that a procedure is distinct from another service performed on the same day — typically used to override a NCCI bundling edit. CMS introduced the X modifiers (XE, XS, XP, XU) as more specific alternatives that indicate the exact reason why the services are distinct.
XE = Separate encounter. The services were provided at separate encounters on the same date. XS = Separate structure. The services were performed on a separate anatomical structure. XP = Separate practitioner. The services were performed by a different practitioner. XU = Unusual non-overlapping service. The service doesn't overlap with the companion procedure.
Many payers still accept Modifier 59 and don't require the X modifiers. But CMS and Medicare Advantage plans are increasingly requiring the more specific X modifiers. Know your payer mix — some plans will accept 59, others will reject it if an X modifier is more appropriate.
Building Modifier Use into Your Pre-Billing Review
The most effective way to prevent modifier misuse — and its consequences — is a structured pre-billing review that evaluates modifier 25 and 59 use before claims go out. Designate a coder to audit a sample of claims with these modifiers weekly. The audit question is simple: does the documentation support the modifier as used? If the answer is no for any claim, pull it, correct it, and identify the documentation gap.
Track your modifier 25 and 59 utilization rates by provider. If one provider uses modifier 25 on 70% of procedure days while another uses it on 15%, investigate the difference. The explanation might be legitimate — different patient populations, different clinical workflows — or it might be a documentation and training problem that needs correction before OIG finds it first.
